Results 151 to 160 of about 1,342,432 (229)

Letter: Low-FODMAP Diet in Irritable Bowel Syndrome-Beyond the Hype! [PDF]

Aliment Pharmacol Ther
Shiha MG, Keszthelyi D.
europepmc   +1 more source

Vaporised etomidate (“space oil”) misuse: A narrative review

Hong Kong Journal of Emergency Medicine, Volume 33, Issue 5, October 2026.
Abstract Background Etomidate, a well‐established intravenous induction agent valued for haemodynamic stability, has emerged as a recreational drug via e‐cigarette vaping (“space oil”), particularly in Asia, including Hong Kong, prompting regulatory controls amid rising emergency presentations.
Sui Wa Au, Yu‐Yeung Yip
wiley   +1 more source

Irritable bowel syndrome management: current insights. [PDF]

Singapore Med J
Ang D.
europepmc   +1 more source

When Food Avoidance Meets Compatible Diagnostic Criteria: Avoidant/Restrictive Food Intake Disorder Features in Irritable Bowel Syndrome. [PDF]

Neurogastroenterol Motil
In our cohort of patients with IBS, 47.5% had ARFID‐like symptoms (relying solely on the NIAS‐Fr), and 33.4% met the DSM‐5 compatible ARFID criteria (through medical chart review of medical impairment, eating disorder diagnosis, and psychosocial impairment assessed with the IBS‐QOL). Applying the DSM‐5 compatible ARFID criteria identified patients with
Mikhael-Moussa H, Aupetit A, Guérin O, Desprez C, Monti F, Grosjean J, Gourcerol G, Leroi AM, Achamrah N, Melchior C.   +9 more
europepmc   +2 more sources

Hong Kong Poison Information Centre: Annual report 2022

Hong Kong Journal of Emergency Medicine, Volume 33, Issue 5, October 2026.
Abstract Background The Hong Kong Poison Information Centre (HKPIC) has been providing consultation services to healthcare professionals and collecting epidemiological data on poisoning in Hong Kong since 2005. Objective To analyse and report the poisoning data from HKPIC in 2022.
Tin Yat Anthony Chow, Chi Keung Chan, Shan Liu, Sze Hong Ng, Man Li Tse   +4 more
wiley   +1 more source

Application of neuromodulation techniques in irritable bowel syndrome. [PDF]

Front Neurosci
Zhang Y, Gao L, Zhang X, Sun W, Wang M, Zhang T, Wang X.   +6 more
europepmc   +1 more source

Extracellular Vesicle‐Encapsulated Small RNAs From Clostridium Butyricum Modulate Host Intestinal Lipid Metabolism

Journal of Extracellular Vesicles, Volume 15, Issue 10, October 2026.
Extracellular vesicles (EVs) derived from C. butyricum can enter intestinal epithelial cells and mediate the anti‐lipid absorption effects by delivering miRNA‐like RNAs (milRNAs), particularly milRNA‐3020179, which primarily targeted host genes majorly including PPARα. Deletion of milRNA‐3020179 in C. butyricum abolished its effects on lipid deposition
Hong Hu, Yiwen He, Jing Liang, Qi Han, Xuqing Liang, Guangtian Cao, Yulong Tang, Liuqin He, Yulong Yin, Xihong Zhou   +9 more
wiley   +1 more source

The Cost of the Cure: Antibiotic Exposure as a Risk Factor for Irritable Bowel Syndrome. [PDF]

Antibiotics (Basel)
Ismaiel A, Almonajjed MB, Abdelghafar A, Wardeh M, Grad S, Surdea-Blaga T, Popa SL, Ismaiel M, Abosheisha M, Krauss AF, Grama P, Bataga S, Dumitrascu DL.   +12 more
europepmc   +1 more source

A Multicenter, Prospective Real‐World Study of Simethicone–Activated Charcoal in Patients With Persistent Dyspeptic Symptoms Despite Acid Suppression (SIMAC Study)

JGH Open, Volume 10, Issue 10, October 2026.
ABSTRACT Background Persistent gas‐predominant dyspeptic symptoms affect many patients despite adequate proton pump inhibitor (PPI) therapy, reflecting mechanisms beyond acid secretion. We evaluated the real‐world effectiveness and safety of simethicone (80 mg) plus activated charcoal (250 mg) in adults with persistent symptoms despite prior PPI ...
Ashish Kumar, D. V. Sreenivas, Sambit Kumar Behera, Guduru Raghavendra Srinivas Rao, G. S. Sameer Kumar, Jaya Ghosh Chatterjee, Nalini Kant Choudhary, Ravi Shankar Bagepally, Shekhar Puri, S. M. A. Rizvi, Rahul Pathak, Shruti Pal   +11 more
wiley   +1 more source

Irritable Bowel Syndrome [PDF]

Korean J Gastroenterol
Nathani RR, Sodhani S, Goosenberg E.
europepmc   +2 more sources